Curi Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-510
Closed -$297K 80
2023
Q4
$297K Buy
510
+24
+5% +$14K 0.04% 124
2023
Q3
$261K Sell
486
-133
-21% -$68.5K 0.04% 129
2023
Q2
$290K Sell
619
-3
-0.5% -$1.26K 0.04% 132
2023
Q1
$214K Buy
+622
New +$210K 0.03% 158
2022
Q3
Sell
-275
Closed -$89K 478
2022
Q2
$89K Sell
275
-150
-35% -$45K 0.02% 184
2022
Q1
$121K Buy
425
+191
+82% +$49.2K 0.02% 142
2021
Q4
$64K Buy
+234
New +$59.3K 0.01% 175
2021
Q1
Sell
-264
Closed -$44K 311
2020
Q4
$44K Buy
+264
New +$39.4K 0.03% 159

Other funds holding LLY

Curi Wealth Management's LLY Position: Q1 2024 in Review

Curi Wealth Management sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 510 shares — an estimated $297K sold.

Curi Wealth Management first reported a position in LLY in Q4 2020 and held it in 8 quarters. The position peaked at $297K in Q4 2023. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Curi Wealth Management reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • Curi Wealth Management sold 510 Eli Lilly shares in Q1 2024, an estimated $297K.
  • Curi Wealth Management first reported a position in Eli Lilly in Q4 2020 and held it in 8 quarters.
  • Curi Wealth Management's Eli Lilly position peaked at $297K in Q4 2023.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Curi Wealth Management's 13F filing for Q1 2024.